Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07450911

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
ReValve Solutions Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.

Conditions

Interventions

TypeNameDescription
DEVICEReValve SystemMitral Valve Replacement Device

Timeline

Start date
2026-01-27
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2026-03-05
Last updated
2026-03-05

Locations

3 sites across 1 country: Georgia

Source: ClinicalTrials.gov record NCT07450911. Inclusion in this directory is not an endorsement.